Omega Healthcare beats Q2 2026 FFO estimates and raises full-year AFFO guidance to $3.22–$3.26
- Reported fiscal Q2 2026 non-GAAP EPS of $1.19, up 159% year over year, beating estimates.
- Fiscal Q2 2026 revenue was $262.7M, rising 12% year over year but missing analyst estimates.
- Reported Q2 2026 FFO of $0.83 per share for the quarter.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.